Cargando…
Limitations to the use of bromelain-based enzymatic debridement (NexoBrid(®)) for treating diabetic foot burns: a case series of disappointing results
BACKGROUND: Bromelain-based enzymatic debridement with Nexobrid® (Mediwound) is an alternative to traditional surgical tangential excision of deep dermal and full thickness burns. Early literature suggests that Nexobrid debridement could reduce the number of operations, infection rates, inpatient st...
Autores principales: | Berner, Juan Enrique, Keckes, Dejan, Pywell, Matthew, Dheansa, Baljit |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6295758/ https://www.ncbi.nlm.nih.gov/pubmed/30574406 http://dx.doi.org/10.1177/2059513118816534 |
Ejemplares similares
-
Bromelain-based enzymatic burn debridement: Spanish multidisciplinary consensus
por: Serracanta, Jordi, et al.
Publicado: (2022) -
Abstract: Retrospective Study Comparing Efficacy of Enzymatic Debridement with Nexobrid with Traditional Treatment in Circular Deep Burns in Prevention of the Compartment Syndrome
por: Salmeron-Gonzalez, Enrique, et al.
Publicado: (2018) -
A Questionnaire-Based Study to Obtain a Consensus from 5 Polish Burns Centers on Eschar Removal by Bromelain-Based Enzymatic Debridement (Nexobrid(®)) in Burns Following the 2020 Updated European Consensus Guidelines
por: Korzeniowski, Tomasz, et al.
Publicado: (2022) -
Successful treatment of mixed depth flame burns using enzymatic debridement with Nexobrid™ in a patient with aggressive systemic sclerosis (scleroderma)
por: Wickham, Neil, et al.
Publicado: (2019) -
622 Oral Ketamine Administration During Bromelain Based Enzymatic Debridement of Burn Injury
por: Halicki, Elizabeth, et al.
Publicado: (2022)